Cloudastructure, Inc.
CSAI Nasdaq Services-Computer Programming, Data Processing, Etc. Financials FY2023βFY2025
What Cloudastructure, Inc. does
No business description yet.
- Legal name
- CLOUDASTRUCTURE, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 31, 2026
- Accession Β· CIK
- 0001683168-26-002561
0001709628
Revenue and margins
Cloudastructure, Inc. had $5.1M of revenue in fiscal 2025, up 271.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$7.2M in fiscal 2025, β142.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Cloudastructure, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 29.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably Cloudastructure, Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $4.0M | $0.1M | $8.5M |
| Current ratio | 17.8x | 0.5x | 3.9x |
| Quick ratio | 16.6x | 0.3x | 3.8x |
| Total assets | $5.0M | $0.6M | $10.1M |
| Total liabilities | $0.3M | $1.1M | $2.5M |
| Shareholders' equity | $4.7M | β$0.5M | $7.6M |
| Net debt (β = net cash) | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | 3 / 8 | 4 / 8 |
| Accruals ratio | β66.4% | β117.0% | β28.8% |
| Altman Z'' | β10.30 | β303.63 | β13.83 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $0.6M | $1.4M | $5.1M |
| Gross profit | β$0.1M | $0.4M | $1.5M |
| Research and development | $2.0M | $1.3M | $1.9M |
| Operating income | β$8.7M | β$6.2M | β$8.1M |
| Net income | β$9.0M | β$6.5M | β$8.5M |
| Net income to common | β | β$6.5M | β$10.4M |
| Diluted EPS | β | β$0.45 | β$0.55 |
| Diluted shares | 0.01B | 0.01B | 0.02B |
| Cash flow | |||
| Cash from operations | β$5.7M | β$3.3M | β$6.9M |
| Capital expenditure | $0.0M | $0.0M | $0.3M |
| Free cash flow | β$5.8M | β$3.3M | β$7.2M |
| Depreciation and amortization | $0.2M | $0.1M | $0.1M |
| Stock-based compensation | $1.2M | $2.0M | $2.3M |
| Balance sheet | |||
| Cash and short-term investments | $4.0M | $0.1M | $8.5M |
| Current assets | $4.8M | $0.5M | $9.8M |
| Current liabilities | $0.3M | $1.1M | $2.5M |
| Inventory | $0.3M | $0.2M | $0.3M |
| Property and equipment, net | $0.1M | $0.1M | $0.3M |
| Intangible assets | $0.0M | $0.0M | β |
| Total assets | $5.0M | $0.6M | $10.1M |
| Total liabilities | $0.3M | $1.1M | $2.5M |
| Preferred stock | β | $0.0M | $0.0M |
| Shareholders' equity | $4.7M | β$0.5M | $7.6M |
| Margins | |||
| Gross margin | β19.4% | 27.4% | 29.4% |
| Operating margin | β1,435.4% | β453.9% | β160.8% |
| EBITDA margin | β1,401.0% | β448.6% | β159.1% |
| Net margin | β1,483.9% | β479.1% | β167.0% |
| FCF margin | β948.8% | β242.2% | β142.8% |
| Returns | |||
| Return on capital employed | β186.1% | 1,230.8% | β107.4% |
| Return on equity | β192.4% | β312.9% | β238.9% |
| Return on assets | β181.8% | β234.7% | β157.6% |
| Return on tangible equity | β192.4% | β | β137.4% |
| Growth | |||
| Revenue growth | β | 124.7% | 271.4% |
| Share count change | β | 0.1% | 29.3% |
| Financial health | |||
| Current ratio | 17.8x | 0.5x | 3.9x |
| Quick ratio | 16.6x | 0.3x | 3.8x |
| Capital allocation | |||
| Capex / revenue | 7.1% | 2.0% | 6.2% |
| Stock comp / revenue | 190.1% | 149.2% | 46.0% |
| Quality scores | |||
| Piotroski F-score | β | 3.0 | 4.0 |
| Altman Z'' | β10.3 | β303.6 | β13.8 |
| Accruals ratio | β66.4% | β117.0% | β28.8% |
Source: SEC EDGAR XBRL filings (CIK 0001709628). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.